Parkinson's disease. Hemiparkinsonism Paralysis agitans Parkinsonism or Parkinson disease: NOSidiopathicprimary
Conditions
Interventions
Intervention 1: Intervention Group (1): The treatment is designed based on the group rehabilitation approach and the framework of the Model of Human Occupation (MOHO). MOHO emphasizes the interaction
these sports involve balance exercises, mild strength activities, coordinated hand-eye movements, and simple team activities designed for levels 1 to 3 of Hoehn and Yahr, representing various ability
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: •Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist, based on established criteria such as the UK Brain Bank Disease severity at stages 1 to 3 according to the Hoehn and Yahr scale Age range approximately between 30 to 80 years old Adequate cognitive function, typically defined by a score of 24 or higher on the Mini Mental State Examination (MMSE) or Montreal Cognitive Assessment (MoCA) Ability to perform motor tasks relevant to the intervention, including uni-manual and bi-manual activities of daily living Minimum educational level to ensure comprehension and participation in therapy Willingness and ability to provide informed consent and participate actively in group therapy sessions Having a stable medication regimen for Parkinson's disease symptoms for at least two months prior to enrollment in the study
Exclusion criteria
Exclusion criteria: Significant psychiatric disorders such as major depression, psychosis, or severe anxiety that may interfere with participation Other neurological or musculoskeletal conditions that significantly affect motor function (e.g., stroke, severe arthritis) Participation in other clinical trials or rehabilitation programs that could confound results Severe sensory impairments (e.g., vision or hearing loss) that limit ability to engage in therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Emotional status. Timepoint: Before the start of the intervention, 4 weeks after the intervention, 4 weeks after the completion of the intervention. Method of measurement: The emotional status is assessed using the Hospital Anxiety and Depression Scale (HADS) and the Beck Depression Inventory (BDI).;Cognitive function. Timepoint: Before the start of the intervention, 4 weeks after the intervention, 4 weeks after the completion of the intervention. Method of measurement: Cognitive function is evaluated with the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination (MMSE).;Motor function. Timepoint: Before the start of the intervention, 4 weeks after the intervention, 4 weeks after the completion of the intervention. Method of measurement: Motor planning and performance are measured by Part III of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS Part III) and the Purdue Pegboard Test. Additionally, a motion analysis system may be used for more precise quantitative assessment of motor function. | — |
Secondary
| Measure | Time frame |
|---|---|
| Participation in activity of daily living (ADL). Timepoint: Before the start of the intervention, 4 weeks after the intervention, 4 weeks after the completion of the intervention. Method of measurement: The Canadian Occupational Performance Measure (COPM) for evaluating patient's participation in Activities of daily living. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZeinab Fathipour-Azar
Tabriz University of Medical Sciences
Outcome results
None listed